TREX1-MODULATOREN
European patent · EP3891145 · Deleted
Register entry
- Publication number
- EP3891145
- Application number
- EP19828476
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Dec 6, 2019
- Published
- Oct 13, 2021
- Granted
- Apr 12, 2023
- Deleted
- Jul 23, 2026
- Reason
- Annual fee unpaid
- IPC classes
- C07D 413/12 (2006.01)C07D 413/14 (2006.01)A61K 31/513 (2006.01)A61K 31/551 (2006.01)A61P 35/00 (2006.01)
- Priority
- US 201862776031 P 06.12.2018
- PCT application
- PCT/US2019/064825 06.12.2019
- PCT publication
- WO2020/118133 11.06.2020
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jul 23, 2026
Deleted, fee unpaid
- Status of protective title
- Active → Cancelled
- Cancellation date
- 23.07.2026
- Cause for cancellation
- Non-payment of renewal fee
Published in Swissreg on 23.07.2026
- Jan 8, 2025
Next annual fee due on
- Next annual fee due on
- 31.12.2024 → 31.12.2025
Published in Swissreg on 08.01.2025
- Feb 21, 2024
Change
Published in Swissreg on 21.02.2024
- Jan 1, 2024
Change
Published in Swissreg on 01.01.2024
- Nov 7, 2023
Address changed
- Owner
- Constellation Pharmaceuticals, Inc., 215 First Street, Suite 200, Cambridge, MA 02142, USA → Constellation Pharmaceuticals, Inc., 470 Atlantic Avenue, Suite 1401, Boston, MA 02210 US, USA
Published in Swissreg on 07.11.2023
- Apr 12, 2023
Granted
Published in Swissreg on 12.04.2023
Parties
Inventor
Arlington, MA 02474, US
Arlington, MA 02474, US
Cambridge, MA 02142, US
Lynn, MA 01902, US
Cambridge, MA 02141, US
Somerville, MA 02144, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.